ArticleBMC pediatrics2025
Milk temperature reducing necrotizing enterocolitis in very preterm infants: study protocol for a randomized controlled trial.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundNecrotizing enterocolitis (NEC) is a common and serious gastrointestinal condition among preterm infants. Factors such as infection, inflammation, and improper feeding are believed to contribute to its onset, but its precise pathophysiology remains unclear. Cold exposure, including feeding at low temperatures, has been associated with increased risks of NEC, yet the direct relationship between feeding temperature and NEC development remains underexplored. This study aims to assess the impact of thermostatic versus standard feeding on the incidence of stage 2 or higher NEC in very preterm infants.
methodsThis randomized controlled trial involves preterm infants (< 32 weeks gestational age) admitted to a neonatal intensive care unit. Participants are randomly assigned to receive either thermostatic feeding, with milk maintained at a set temperature throughout feeding, or standard feeding, where milk is allowed to reach room temperature. Both breast milk and formula are used based on clinical guidelines. Primary outcomes include the incidence of ≥ stage 2 NEC, while secondary outcomes involve the incidence of bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP) > 2nd stages, intraventricular hemorrhage (IVH) > 2nd grades, time to achieve total gastrointestinal nutrition, weekly weight growth, frequency of feeding intolerance, extrauterine growth restriction, and late-onset sepsis. EXPECTED
resultsThe study expects to identify a significant reduction in NEC incidence among infants receiving thermostatic feeding compared to those in the standard feeding group. Additionally, improvements in feeding tolerance, weekly weight growth, and time to achieve full gastrointestinal nutrition are anticipated.
conclusionThis study aims to clarify the relationship between feeding temperature and NEC risk, potentially influencing future neonatal care guidelines. By identifying optimal feeding practices, this trial aims to reduce the morbidity and mortality associated with NEC in very preterm infants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.